Financials
- Market Capitalization 1.94 B
- Employee 87
- Founded 2018
- CEO N/A
- Website www.tyra.bio
- Headquarter Delaware, United States
- FIGI BBG00RCQD9D1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-13.08
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2013 | ATAI AtaiBeckley Inc. - Common Stock | 5.51 USD | +10.87% | +9.11% | +38.10% | +39.49% | 2.03 B USD | ||
| 2016 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.80 USD | +0.73% | +2.98% | +34.69% | +109.47% | 1.94 B USD | ||
| 2041 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 22.65 USD | +3.05% | -6.75% | +21.84% | +100.44% | 1.91 B USD | ||
| 2051 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.32 USD | +2.30% | -22.20% | +4.23% | -2.92% | 1.86 B USD |